Public, NASDAQ:MAPP
NASDAQ Global Market
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
Date: Wed, 23 Jul 2008 19:23:24 GMT
Tags:
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs
FOXBusiness - Jul 23, 2008
FOXBusiness - Jul 23, 2008
MOUNTAIN VIEW , Calif . , July 23 , 2008 / PRNewswire - FirstCall via COMTEX / - - - - MAP Pharmaceuticals , Inc . ( Nasdaq : MAPP ) today announced the appointment of Donald J . Kellerman , ...
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
Date: Wed, 16 Jul 2008 11:19:45 GMT
Tags:
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
PR Newswire (press release) - Jul 16, 2008
PR Newswire (press release) - Jul 16, 2008
MOUNTAIN VIEW , Calif . , July 16 / PRNewswire - FirstCall / - - MAP Pharmaceuticals , Inc . ( Nasdaq : MAPP ) announced that the positive results from a Phase 2 study evaluating the safety , ...
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
Date: Wed, 16 Jul 2008 11:14:38 GMT
Tags:
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
Earthtimes (press release) - Jul 16, 2008
Earthtimes (press release) - Jul 16, 2008
MOUNTAIN VIEW , Calif . , July 16 - - MAP Pharmaceuticals , Inc . ( Nasdaq : MAPP ) announced that the positive results from a Phase 2 study evaluating the safety , tolerability and pharmacokinetics ...
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
Date: Tue, 15 Jul 2008 11:31:07 GMT
Tags:
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
RedOrbit - Jul 15, 2008
RedOrbit - Jul 15, 2008
MOUNTAIN VIEW , Calif . , July 14 / PRNewswire - FirstCall / - - MAP Pharmaceuticals , Inc . today announced it has initiated its Phase 3 clinical program to evaluate MAP0004 as a potential treatment ...
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
Date: Mon, 14 Jul 2008 22:00:00 GMT
Tags:
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
PR Newswire (press release) - Jul 14, 2008
PR Newswire (press release) - Jul 14, 2008
MOUNTAIN VIEW , Calif . , July 14 / PRNewswire - FirstCall / - - MAP Pharmaceuticals , Inc . ( Nasdaq : MAPP ) today announced it has initiated its Phase 3 clinical program to evaluate MAP0004 ...
MAP Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Medical Affairs (PR Newswire)
Date: Wed, 23 Jul 2008 11:00:00 Etc/GMT
Tags:
MAP Pharmaceuticals, Inc. today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice President, Clinical Development and Medical Affairs.
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion (PR Newswire)
Date: Wed, 16 Jul 2008 11:00:00 Etc/GMT
Tags:
MAP Pharmaceuticals, Inc. announced that the positive results from a Phase 2 study evaluating the safety, tolerability and pharmacokinetics of MAP0004 in adult asthmatics were published in the July issue of Current Medical Research and Opinion.
Map Pharmaceuticals starts migraine drug test (at bizjournals.com)
Date: Mon, 14 Jul 2008 21:25:07 Etc/GMT
Tags:
MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Date: Mon, 14 Jul 2008 21:05:49 Etc/GMT
Tags:
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine (PR Newswire)
Date: Mon, 14 Jul 2008 20:05:00 Etc/GMT
Tags:
MAP Pharmaceuticals, Inc. today announced it has initiated its Phase 3 clinical program to evaluate MAP0004 as a potential treatment for migraine.